Beam Therapeutics (NASDAQ:BEAM) shared promising results from the early stage trial of its genetically modified cell therapy, ...

SOKENDAI and Kyushu University have uncovered the molecular mechanism that drives the "ticking" of the circadian clock in ...

Memorial Sloan Kettering Cancer Center researchers have identified a metabolic switch that determines whether intestinal stem ...

The timing of immunotherapy initiation is not a significant factor in the outcomes of patients with extensive-stage small ...

Summer is here, and the bike is beckoning. Whether you’re rolling through the tree-lined boulevards of Chicago, cruising along Montreal’s Lachine Canal, or dodging tourists in London’s Southbank, ...

A ginger-derived molecule known as EMC shuts down a cancer's fat-making machinery causing it to activate backup systems and ...

Cornell researchers have discovered a new cell signaling pathway involved in ovulation, a potential target for future ...

U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support licensure Advisory Committee meeting scheduled for July 30, 2025 Mid-cycle ...

The team responsible for updating the CDC’s “contraception bible,” which advises doctors on birth control safety, was ...

CHAF1B, a histone chaperone component of the chromatin assembly factor-1 complex, is overexpressed in multiple cancers and ...

CHAF1B, a histone chaperone component of the chromatin assembly factor-1 complex, is overexpressed in multiple cancers and ...

Researchers uncover how 12-hour biological rhythms operate in mammals, exploring their unique mechanisms and potential ...